97 related articles for article (PubMed ID: 2461350)
1. Autoimmune expression of a cytoplasmic protein p60 in mice bearing metastasizing SV40-transformed tumors.
Manneck HE; Pfaff M; Anderer FA
Int J Cancer; 1988 Dec; 42(6):906-12. PubMed ID: 2461350
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen.
Soule HR; Lanford RE; Butel JS
J Virol; 1980 Feb; 33(2):887-901. PubMed ID: 6157837
[TBL] [Abstract][Full Text] [Related]
3. Surface proteins of simian-virus-40-transformed cells.
Chandrasekaran K; Winterbourne DJ; Luborsky SW; Mora PT
Int J Cancer; 1981 Mar; 27(3):397-407. PubMed ID: 6169662
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
Linzer DI; Levine AJ
Cell; 1979 May; 17(1):43-52. PubMed ID: 222475
[TBL] [Abstract][Full Text] [Related]
5. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
6. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
Shearer MH; Bright RK; Lanford RE; Kennedy RC
Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
[TBL] [Abstract][Full Text] [Related]
8. Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.
Kennedy RC; Dreesman GR; Butel JS; Lanford RE
J Exp Med; 1985 Jun; 161(6):1432-49. PubMed ID: 2409201
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the surface proteins of SV40-transformed mouse and human cells: absence of SV40-specific proteins.
Rose TM; Weil R
Int J Cancer; 1983 May; 31(5):639-48. PubMed ID: 6303969
[TBL] [Abstract][Full Text] [Related]
10. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
Blasecki JW; Tevethia SS
Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
[TBL] [Abstract][Full Text] [Related]
11. Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells.
Lange-Mutschler J; Deppert W; Hanke K; Henning R
J Gen Virol; 1981 Feb; 52(Pt 2):301-12. PubMed ID: 6270237
[TBL] [Abstract][Full Text] [Related]
12. SV40 large T-antigen and transformation related protein p53 are associated in situ with nuclear RNP structures containing hnRNA of transformed cells.
Caron de Fromentel C; Viron A; Puvion E; May P
Exp Cell Res; 1986 May; 164(1):35-48. PubMed ID: 3007186
[TBL] [Abstract][Full Text] [Related]
13. Immune response of athymic nude mice to papovavirus SV40 tumor-associated antigens.
Tevethia SS; Waneck G; Tevethia MJ
Int J Cancer; 1977 May; 19(5):700-6. PubMed ID: 193802
[TBL] [Abstract][Full Text] [Related]
14. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
Ansel S; Huet C; Tournier P
Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
[TBL] [Abstract][Full Text] [Related]
15. Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen.
Mernaugh RL; Shearer MH; Bright RK; Lanford RE; Kennedy RC
Cancer Immunol Immunother; 1992; 35(2):113-8. PubMed ID: 1596936
[TBL] [Abstract][Full Text] [Related]
16. Immune control of SV40-induced tumors in mice.
Pan S; Abramczuk J; Knowles BB
Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
[TBL] [Abstract][Full Text] [Related]
17. Reactivity to SV40 T antigen in athymic (nude), anti-thymocyte serum-treated, and normal mice.
Knowles BB; Ford SR; Aden DP
J Immunol; 1977 Jul; 119(1):79-82. PubMed ID: 194983
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of simian virus 40-transformed rat hepatocytes.
Isom HC; Tevethia MJ; Kreider JW
Cancer Res; 1981 Jun; 41(6):2126-34. PubMed ID: 6263461
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
Ansel S
Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766
[TBL] [Abstract][Full Text] [Related]
20. Cellular targets for SV40 large T-antigen.
Lane DP; Simanis V; Bartsch R; Yewdell J; Gannon J; Mole S
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):25-42. PubMed ID: 2415984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
